Citation Impact
Citing Papers
Guillain-Barré syndrome and Campylobacter jejuni: a serological study.
1984
Virus-Induced Autoimmunity: Potential Role of Viruses in Initiation, Perpetuation, and Progression of T-Cell–Mediated Autoimmune Disease
2001
Ultrastructural effects of Guillain-Barréserum in cultures containing only rat Schwann cells and dorsal root ganglion neurons
1987
Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
1992
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
2002 StandoutNature
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy
1996
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Cloning of a human gene encoding the general transcription initiation factor IIB
1991 Nature
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
High-dose methylprednisolone suppresses experimental allergic neuritis in the Lewis rat
1989
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization
1997 Standout
Paraproteinemic Neuropathies
2001
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
1990 Standout
Guillain-Barré syndrome
2016 Standout
Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study
2014
FTY720 modulates human oligodendrocyte progenitor process extension and survival
2007
Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons
1992
Guillain–Barré Syndrome
2012 Standout
Purification of tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme
1995 StandoutNobel
The prevalence of multiple sclerosis in the world: an update
2001
Genetic manipulation of non-segmented negative-strand RNA viruses
1996
CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients
1999
Association betweenCampylobacterInfection and Guillain‐Barré Syndrome
1997
Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
1990 Standout
Cytomegalovirus infection and Guillain-Barre syndrome
1996
Multiple sclerosis
2008 Standout
EPIDEMIOLOGY OF MULTIPLE SCLEROSIS
1996
Principal components analysis corrects for stratification in genome-wide association studies
2006 Standout
Fruit bats as reservoirs of Ebola virus
2005 StandoutNature
Topogenic signals in integral membrane proteins
1988
The epidemiology of multiple sclerosis
2016
Pathogenesis of tissue injury in MS lesions
1999
In vitro demyelination by serum antibody from patients with guillain‐barré syndrome requires terminal complement complexes
1991
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages
2006
A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
1994
Neuroligin 1: A splice site-specific ligand for β-neurexins
1995 StandoutNobel
Campylobacter jejuni strains from patients with guillain‐barré syndrome belong mostly to penner serogrpup 19 and contain β‐N‐acetylglucosamine residues
1993
HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies
1991
Neuromuscular diseases associated with human immunodeficiency virus infection
1988
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden
1990
Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses
1992
Immunopathogenesis and treatment of the guillain‐barré syndrome—part I
1995
Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress
2006
Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identical infections
1998
Serum antibodies to gangliosides in guillain‐barré syndrome
1988
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Role of Infection Due to Campylobacter jejuni in the Initiation of Guillain-Barre Syndrome
1993
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
1998 Standout
Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II
1994 StandoutNatureNobel
Erythropoietin Ameliorates Rat Experimental Autoimmune Neuritis by Inducing Transforming Growth Factor-Beta in Macrophages
2011
The Inflammasomes
2010 Standout
Multiple Sclerosis
2000 Standout
Epidemiology of Multiple Sclerosis: A Critical Overview
1993
Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin
1991
Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection
1996
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis
1992 Standout
Immune Mechanisms in Inflammatory Polyneuropathya
1988
Environmental risk factors in multiple sclerosis aetiology
2004
Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: Susceptibility to cytolysis reflects Schwann cell phenotype
1994
Pathogenesis of Guillain–Barré syndrome
1999
Distinct pattern of age-specific incidence of Guillain-Barré syndrome in Harbin, China
2002
A possible harmful late effect of methylprednisolone therapy on a time cluster of optic neuritis
1989
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE
2006
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 Standout
Nuclear Import of Influenza Virus RNA Can Be Mediated by Viral Nucleoprotein and Transport Factors Required for Protein Import
1995 StandoutNobel
Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk
2001
Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain–Barré syndrome
2002
Multiple sclerosis
2002 Standout
Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome
1991
MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development
2012 StandoutNobel
Humoral factors in peripheral nerve disease
1987
Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent.
1984 StandoutNobel
In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study.
1979
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
Exploring the nature of the translocon-assisted protein insertion
2012 StandoutNobel
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain–Barre syndrome
2000
BENEFICIAL EFFECTS OF PLASMA EXCHANGE IN ACUTE INFLAMMATORY POLYRADICULONEUROPATHY
1984
CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY
1978 Standout
Presence of Cytomegalovirus in Cerebrospinal Fluid of Patients with Guillain‐Barré Syndrome
2004
Sequence homology within the morbilliviruses
1985
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 StandoutScience
RNA Polymerase II Initiation Factor Interactions and Transcription Start Site Selection
1994 StandoutScienceNobel
Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis
1981 Science
Regulation of RNA Synthesis by the Genomic Termini of Vesicular Stomatitis Virus: Identification of Distinct Sequences Essential for Transcription but Not Replication
1999
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
1987
Pathology of the Guillain-Barr� syndrome
1981
In vivo demyelinating activity of sera from patients with Guillain‐Barré syndrome
1982
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis
1998
Assembly and transcription of synthetic vesicular stomatitis virus nucleocapsids
1991
Epidemiologic evidence for multiple sclerosis as an infection
1993
Purification and characterization of yeast RNA polymerase II general initiation factor g
1992 StandoutNobel
A prospective study of acute idiopathic neuropathy. II. Antecedent events.
1988
CONTROLLED TRIAL OF PLASMA EXCHANGE IN ACUTE INFLAMMATORY POLYRADICULONEUROPATHY
1984
Purification and properties of Saccharomyces cerevisiae RNA polymerase II general initiation factor a
1992 StandoutNobel
Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice
2002 StandoutNobel
RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila
2010 StandoutNobel
High-dose steroid therapy in Guillain-Barré syndrome
1988
Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells
1998
Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.
1995
Modification of the Single Tryptophan Residue of Staphylococcal Nuclease by a New Mild Oxidizing Agent
1970 StandoutNobel
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Inflammatory infiltrates in the spinal cord of patients with Guillain-Barr� syndrome
2003
Rapid Evolution of RNA Genomes
1982 StandoutScience
The Berkeleyamides, Amides from the Acid Lake FungusPenicillum rubrum
2008
NONSEGMENTED NEGATIVE-STRAND RNA VIRUSES: Genetics and Manipulation of Viral Genomes
1998
The spectrum of antecedent infections in Guillain-Barre syndrome
1998
Sequence Homology Between Certain Viral Proteins and Proteins Related to Encephalomyelitis and Neuritis
1985 StandoutScienceNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.
1973
Utilization of ribonucleotides and RNA primers by Tetrahymena telomerase.
1995 StandoutNobel
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
Common circuit defect of excitatory-inhibitory balance in mouse models of autism
2009 StandoutNobel
Allergic encephalomyelitis: Cleavage of the C-tryptophyl bond in the encephalitogenic basic protein from bovine myelin
1969
Structure and expression of the rat inositol 1,4,5-trisphosphate receptor.
1990 StandoutNobel
Yeast RNA polymerase II initiation factor e: isolation and identification as the functional counterpart of human transcription factor IIB.
1992 StandoutNobel
Preceding infections, immune factors, and outcome in Guillain–Barre syndrome
2001
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
1989
Postoperative contrast enhancement in patients with brain tumor
1985
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
Inflammatory demyelinating peripheral neuropathies associated with human T‐cell lymphotropic virus type III infection
1987
Reconstitution of transcription with five purified initiation factors and RNA polymerase II from Saccharomyces cerevisiae
1992 StandoutNobel
LAV Revisited: Origins of the Early HIV-1 Isolates from Institut Pasteur
1991 StandoutScienceNobel
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
2008
Works of Peter C. Dowling being referenced
Beneficial effect of erythropoietin on experimental allergic encephalomyelitis
2004
Rescue of Synthetic Measles Virus Minireplicons: Measles Genomic Termini Direct Efficient Expression and Propagation of a Reporter Gene
1995
Erythropoietin: A Potent Inducer of Peripheral Immuno/Inflammatory Modulation in Autoimmune EAE
2008
Caspase-1 expression in multiple sclerosis plaques and cultured glial cells
2002
Measles virus L protein evidences elements of ancestral RNA polymerase
1988
Platelet-derived growth factor-? receptor-positive oligodendroglia are frequent in multiple sclerosis lesions
2001
Measles Vaccination Does Not Prevent Multiple Sclerosis
1990
VPA-induced apoptosis and behavioral deficits in neonatal mice
2008
Cell death and birth in multiple sclerosis brain
1997
Sequence variability and function of measles virus 3′ and 5′ ends and intercistronic regions
1988
Declining incidence of multiple sclerosis in the Orkney Islands
1985
FINE STRUCTURAL ASPECTS OF DEMYELINATION IN VITRO. THE EFFECTS OF GUILLAIN-BARRÉ SERUM
1971
Possible beneficial effect of high‐dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis
1980
The role of autoantibody and immune complexes in the pathogenesis of Guillain-Barre syndrome
1981
Mycoplasma antibody in guillain‐barré syndrome and other neurological disorders
1980
Effect of high–dose intravenous steriod administration on contrast‐enhancing computed tomographic scan lesions in multiple sclerosis
1984
Guillain-Barré Syndrome in Greater New York-New Jersey
1977
Pattern of cellular and humoral events in experimental allergic encephalomyelitis
1968
Multiple sclerosis and distemper in Iceland 1966-1978
2009
Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis
1979
Role of infection in Guillain-Barr� syndrome: Laboratory confirmation of herpesviruses in 41 cases
1981
Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins
1985
Multiple sclerosis and viruses
1980
The ultrastructure of circulating immunocytes in Guillain‐Barre syndrome
1970
Serum 19S and 7S demyelinating antibodies in multiple sclerosis.
1968